Volume 3, Issue 3 (2021)
Commentary
Efferocytosis and Anthrax: Implications for Bacterial Sepsis?
J Cell Immunol, 2021, 3, 133 - 139
Joshua S. Mytych, Zijian Pan, A. Darise Farris
[DOI No.: https://doi.org/10.33696/immunology.3.090]
Review Article
Ca2+/calmodulin-dependent Protein Kinases in Leukemia Development
J Cell Immunol, 2021, 3, 144 - 150
Changhao Cui, Chen Wang, Min Cao, Xunlei Kang
[DOI No.: https://doi.org/10.33696/immunology.3.091]
Short Communication
Promoter Reporter Systems for Imaging of Cells Transplanted into Post-infarcted Heart
J Cell Immunol, 2021, 3, 151 - 155
Katarzyna Fiedorowicz, Maciej Kurpisz
[DOI No.: https://doi.org/10.33696/immunology.3.092]
Commentary
Duration of SARS-CoV-2 Infectivity
J Cell Immunol, 2021, 3, 156 - 163
Seitz Tamara, Kelani Hasan, Wenisch Christoph, Laferl Hermann
[DOI No.: https://doi.org/10.33696/immunology.3.093]
Commentary
Unconventional Approaches to Direct Detection of Borreliosis and Other Tick Borne Illnesses: A Path Forward
J Cell Immunol, 2021, 3, 164 - 172
Lance Liotta, Alessandra Luchini
[DOI No.: https://doi.org/10.33696/immunology.3.094]
Short Communication
Increased Binding Affinity of Furin to D614G Mutant S-glycoprotein May Augment Infectivity of the Predominating SARS-CoV-2 Variant
J Cell Immunol, 2021, 3, 173 - 176
Sardar Sindhu, Rasheed Ahmad, Fahd Al-Mulla
[DOI No.: https://doi.org/10.33696/immunology.3.095]
Commentary
Murine Models of Alcohol Consumption: Imperfect but Still Potential Source of Novel Biomarkers and Therapeutic Drug Discovery for Alcoholic Liver Disease
J Cell Immunol, 2021, 3, 177 - 181
Khaled Alharshawi, Costica Aloman
[DOI No.: https://doi.org/10.33696/immunology.3.096]
Review Article
The Variable Immune Response to SARS-CoV-2 Infection and Potential Treatment with Combination IL-15 and IL-21
J Cell Immunol, 2021, 3, 182 - 190
Stephen William Wilz
[DOI No.: https://doi.org/10.33696/immunology.3.097]
Research Article
Sleep Disturbances are a Significant Predictor of Chikungunya Arthritis Flare Severity
J Cell Immunol, 2021, 3, 191 - 197
Sarah R. Tritsch, Richard Amdur, Liliana Encinales, Andres Cadena, Paige Fierbaugh, Geraldine Avendaño, Carlos Andres Herrera Gomez, Karol Suchowiecki, Evelyn Mendoza-Torres, Wendy Rosales, Dennys Jimenez, Carlos Alberto Perez Hernandez, Alfonso Sucerquia Hernandez, Paula Bruges Silvera,Yerlenis Galvis Crespo, Alberto David Cabana Jimenez, Jennifer Carolina Martinez Zapata, Christopher N. Mores, Gary S. Firestei, Gary Simon, Aileen Y.Chang
[DOI No.: https://doi.org/10.33696/immunology.3.098]
Commentary
The Potential of Combination Therapies and Patient Stratification to Improve CCR2 Inhibition Therapeutics
J Cell Immunol, 2021, 3, 198 - 200
Jason E. Duex, Dan Theodorescu